Clinical Trial Update: A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes [Phase 2]

View source ↗

Summary

A parallel-group Phase II study of KCT-0809 in dry eye disease has completed its conduct.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• KCT-0809

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 2 | Status: COMPLETED